BioCentury
ARTICLE | Company News

CAT accesses Incyte's LifeSeq

December 19, 2001 8:00 AM UTC

Cambridge Antibody Technology (LSE:CAT; CATG) received access to INCY's LifeSeq Gold database and sequence-verified cDNA clones. In addition, CAT has an option to receive exclusive licenses to discove...